Love Maharashtra? Then you wil love Marathikatta!
Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                    Movies   Aviation   Pharma   About Us   Feedback   Links
CARDIOVASCULAR DRUG PM101
 


HollisterStier inks pact with Prism Pharma on cardiovascular drug PM101

BY OUR PHARMA CORRESPONDENT
March 6, 2006

Sterile injectable products maker HollisterStier Contract Manufacturing has signed a Letter of Intent with Prism Pharmaceuticals, Inc. to develop a process for compounding and fill/finishing Prism's PM101, an acute care cardiovascular 
drug.

HollisterStier is producing PM101 registration material for clinical trials and is supporting Prism Pharmaceuticals filing of a New Drug Application (NDA). PM101 will be filled into vials and syringes.

HollisterStier is a contract manufacture of quality sterile injectables for the global pharmaceutical and biopharmaceutical market. Based in Spokane, Washington, the company is committed to meeting customer expectations in all aspects of our business from quality manufacturing to regulatory support.

Based in King of Prussia, Pennsylvania, Prism Pharmaceuticals, Inc. is a specialty pharmaceutical company developing and commercializing acute care cardiovascular products.

More related stories from Pharma


Healing prayers no cure for the ill, says study

Pulmonary hypertension drug PulmoLAR in human trial

Pharma markets in China, Korea, Mexico, Russia & Turkey gather pace

Pfizerís anxiety drug Lyrica gets EU nod

Asymmetrical breasts: A presage to cancer?

Dream to eradicate polio still far off

GlaxoSmithKline loses fluticasone case

Able files recast plan with bankruptcy court

Ranbaxy in pact with Zenotech on cancer drugs

Lupin and Aspen to form JV on TB drugs

Blood cancer drug Ceflatonin gets orphan drug status

Bangladesh to set up API park; to export drugs worth Tk 8.50 cr to Burma

Wockhard Limited: A profile
Cipla Ltd company profile

 

 

 

Auto news for auto freaks! iDrive.in
DWS community! / Cricket blog

 

Latest Stories in Pharma

 Vertex commences phase II studies for Aurora kinase inhibitor VX-680

GlaxoSmithKline starts H5N1 avian flu vaccine trials in Germany, Belgium

Novartis acquires rights for two drug leads

Serono plans major acquisitions

Samaritan to sell Amphocil in Greece

HIV infection cases fall in South India

Flu drug: Erimos, NC State University seek patent for EM-1421

HollisterStier inks pact with Prism Pharma on cardiovascular drug PM101

Erbitux approved for head and neck cancer in Europe

EPIX Pharmaceuticals merges with Predix

Avanir's involuntary emotional expression disorder (IEED) drug Neurodex gets priority review

 Death of women raises alarm on abortion pillís safety

Prestwick gets approvable letter for Xenazine for treatment of chorea with HD

Nexavar - Kidney cancer drug gets Swiss nod

Anti-rejection drug Prograf approved in US

 

Latest Stories in Pharma

Archived Pharma stories

 

Latest updates    Contact Us - Feedback    About Us